CareDx to Report Fourth Quarter and Full Year 2024 Financial Results
11 februari, 13:05
11 februari, 13:05
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the fourth quarter and full year 2024 after market close on Wednesday, February 26, 2025. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Individuals interested in listening to the conference call may do so by dialing 1-800-267-6316 for domestic callers or 1-203-518-9783 for international callers. Please reference Conference ID: CareDx. To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredx.com.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250211346743/en/
11 februari, 13:05
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the fourth quarter and full year 2024 after market close on Wednesday, February 26, 2025. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Individuals interested in listening to the conference call may do so by dialing 1-800-267-6316 for domestic callers or 1-203-518-9783 for international callers. Please reference Conference ID: CareDx. To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredx.com.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250211346743/en/
Analyser

Aktieråd


SBB

Inflationen
Analyser

Aktieråd


SBB

Inflationen
1 DAG %
Senast

Stockholmsbörsen
12 december, 17:47
Börsen föll tillbaka – stänger veckan rött
Castellum
12 december, 17:27
Castellums VD shoppar loss
Nordea Bank
12 december, 17:02
Storbankerna är dyrare än vanligt – vi slopar köpråden
blankning
12 december, 16:41
Här är de mest blankade aktierna just nu
Coffee Stain Group B
12 december, 14:25
Analys: Uppsidan lockar i Embracers avknoppning
OMX Stockholm 30
1 DAG %
Senast
2 821,01